Indivior PLC (INDV) shares are soaring in Monday's trading session, with the stock climbing 5.01% as of 11:08 AM. The pharmaceutical company's stock is experiencing significant bullish momentum, outperforming the broader market.

The surge in Indivior's stock price comes on the heels of a notable update from Stifel, a well-respected financial services firm. Stifel has raised its target price for Indivior from $28 to $36, representing a substantial increase in their valuation of the company. This upward revision in the target price has evidently sparked investor enthusiasm, driving the stock's impressive gains.

The increased target price from Stifel may suggest growing confidence in Indivior's business prospects and future performance. Investors are likely interpreting this as a positive signal about the company's potential for growth and profitability. As the trading day progresses, market participants will be closely watching to see if Indivior can maintain its momentum and if other analysts follow suit with similarly optimistic outlooks.